Rare diseases
Investigational molecules
Locations
Study to evaluate the long-term safety and effectiveness of lunsekimig in adults with moderate to severe asthma
SpainA study testing molnupiravir in adults with COVID-19 who are not hospitalized and are at high risk for serious illness
SpainLong-term safety study of deucravacitinib compared to ustekinumab in adults with moderate to severe plaque psoriasis
SpainA Study Testing How Well Bimekizumab Works and How Safe It Is for Adults with Palmoplantar Pustulosis
SpainA Study of Ivonescimab Combined with Fluorouracil, Folinic Acid, and Oxaliplatin Compared to Bevacizumab for Patients with Metastatic Colorectal Cancer
SpainA Study to Test if Rinvecalinase Alfa is Safe and Works for Treating Acute Ischemic Stroke in Patients with Moderate Stroke Severity
SpainStudy of ruxolitinib cream for children aged 6 to 12 years with non-segmental vitiligo
SpainLong-term safety study of oral povorcitinib in patients with hidradenitis suppurativa, prurigo nodularis, or vitiligo who previously participated in clinical trials
SpainLong-term safety and effectiveness study of APG777 injection in patients with moderate-to-severe atopic dermatitis who previously received APG777 treatment
SpainStudy of vicadrostat and empagliflozin combination in patients with type 2 diabetes, high blood pressure and cardiovascular disease
SpainStudy of BI 1291583 tablets taken once daily for 76 weeks in adults with bronchiectasis
SpainStudy of tulisokibart compared to placebo in adults with moderate to severe Crohn's disease
SpainTell us about your condition – we search every trial in Europe and connect you with the right site.
